意外胆囊癌防治策略研究进展
摘要
关键词
全文:
PDF参考
FreddieBrayBSc, MSc, PhD, et al.Globalcancerstatistics2018: GLOBOCANestimatesofincidenceandmortalityworldwidefor36cancersin185countries[J]. CA:ACancerJournalforClinicians, 2018,68(6):45-46.
Hsing AW, Gao YT, Han TQ, et al. Gallstones and the risk of biliary tract cancer: a population-based study in China [J]. Br J Cancer, 2007,97(11):1577-1582.
包嘉凌,季沅,金慧涵,等.胆囊切除术中意外发现胆囊癌51例分析[J].江苏医药,2020,46(4):356-361.
Kumar Sandrasegaran,Christine O. Menais. Imaging and Screening of Cancer of the Gallbladder and Bile Ducts[J]. Radiologic Clinics of North America,2017(7):147-151.
Elmasry Mohamed, Lindop Don, Dunne Declan F J, et al. The risk of malignancy in ultrasound detected gallbladder polyps: A systematic review.[J]. International journal of surgery (London, England), 2016,33 Pt A.
杨晓平,韩江,丁友成,等.87例UGC多中心诊疗分析[J].肝胆胰外科杂志,2020,32(11):655-658.
秦建民.UGC误漏诊原因与临床防治策略[J].世界华人消化杂志,2020,28(23):1167-1176.
辛晓利.彩超在胆囊癌诊断中的应用价值探讨[J].中国医药指南,2017,15(35):146-147.
朱铖,周海伟,王红梅,等.超声造影与增强CT在胆囊疾病诊断中的对比分析[J].医学影像学杂志,2011,21(1):65-68.
冉勇.多排螺旋CT与MRI在胆囊癌诊断中的应用价值[J].医疗装备,2020,33(20):35-36.
杨新焕,袁曙光,闫东,等.原发性胆囊癌的MRI诊断[J].放射学实践,2010,25(2):174-177.
张永东.血清CA199、CA242、CA125联合检测对胆囊癌患者诊断的临床价值研究[J].肝胆外科杂志,2016,24(2):106-110.
钱靖,陆斐斐.肿瘤标志物CA19-9联合超敏C反应蛋白在胆囊癌早期诊断中的意义分析[J].全科口腔医学电子杂志,2018,5(7):43-44.
王志炎.腹腔镜胆囊切除术意外胆囊癌的治疗[D].杭州:浙江大学,2015.
Fong Y, Jarnagin W, Blumgart LH. Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention[J]. Ann Surg, 2000(4):557-69.
Goetze TO, Paolucci V. The prognostic impact of positive lymph nodes in stages T1 to T3 incidental gallbladder carcinoma: results of the German Registry[J]. Surg Endosc, 2012(5):1382-1389.
Jarnagin WR, Ruo L, Little SA, et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies[J]. Cancer, 2003(8):1689-1700.
DOI: http://dx.doi.org/10.12345/yzlcyxzz.v4i6.7959
Refbacks
- 当前没有refback。
此作品已接受知识共享署名-非商业性使用 4.0国际许可协议的许可。